Experienced in Aspergillosis

Dr. Michael Denenberg

Pulmonary Medicine
Office
370 Herlong Ave Ste 200, 
Rock Hill, SC 
Offers Telehealth
Experienced in Aspergillosis
Office
370 Herlong Ave Ste 200, 
Rock Hill, SC 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Michael Denenberg is a Pulmonary Medicine provider in Rock Hill, South Carolina. Dr. Denenberg is rated as an Experienced provider by MediFind in the treatment of Aspergillosis. His top areas of expertise are Emphysema, Bullae, Pleurisy, Pleural Effusion, and Advanced Bronchoscopy.

His clinical research consists of co-authoring 3 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Pulmonary Medicine
Licenses
Sleep Medicine in SC
Hospital Affiliations
Piedmont Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Absolute Total Care South Carolina
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medical Mutual
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 15 Less Insurance Carriers -

Locations

Office
370 Herlong Ave Ste 200, Rock Hill, SC 29732
Call: 803-980-5864

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Phase 2b Randomized, Double-blind, Placebo-controlled, Repeat-dose, Multicenter Trial to Evaluate the Efficacy, Safety and Tolerability of HZN-825 in Subjects With Idiopathic Pulmonary Fibrosis
A Phase 2b Randomized, Double-blind, Placebo-controlled, Repeat-dose, Multicenter Trial to Evaluate the Efficacy, Safety and Tolerability of HZN-825 in Subjects With Idiopathic Pulmonary Fibrosis
Enrollment Status: Terminated
Publish Date: December 03, 2025
Intervention Type: Drug
Study Drug: HZN-825
Study Phase: Phase 2
A 52-week, Randomised, Double-blind, Double-dummy, Parallel Group, Multi-centre, Non-inferiority Study Assessing Exacerbation Rate, Additional Measures of Asthma Control and Safety in Adult and Adolescent Severe Asthmatic Participants With an Eosinophilic Phenotype Treated With GSK3511294 Compared With Mepolizumab or Benralizumab
A 52-week, Randomised, Double-blind, Double-dummy, Parallel Group, Multi-centre, Non-inferiority Study Assessing Exacerbation Rate, Additional Measures of Asthma Control and Safety in Adult and Adolescent Severe Asthmatic Participants With an Eosinophilic Phenotype Treated With GSK3511294 Compared With Mepolizumab or Benralizumab
Enrollment Status: Completed
Publish Date: October 15, 2025
Intervention Type: Biological, Drug, Device
Study Drugs: Depemokimab, Mepolizumab, Benralizumab
Study Phase: Phase 3
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis (TETON-1)
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis (TETON-1)
Enrollment Status: Active_not_recruiting
Publish Date: September 08, 2025
Intervention Type: Device, Drug
Study Drug: Treprostinil
Study Phase: Phase 3
A Multi-center, Randomized, Double-blind, Parallel-group, Placebo-controlled Study of Mepolizumab 100 mg SC as add-on Treatment in Participants With COPD Experiencing Frequent Exacerbations and Characterized by Eosinophil Levels (Study 208657)
A Multi-center, Randomized, Double-blind, Parallel-group, Placebo-controlled Study of Mepolizumab 100 mg SC as add-on Treatment in Participants With COPD Experiencing Frequent Exacerbations and Characterized by Eosinophil Levels (Study 208657)
Enrollment Status: Completed
Publish Date: August 15, 2025
Intervention Type: Drug, Biological
Study Drug: Mepolizumab
Study Phase: Phase 3
A 52-week, Randomised, Double-blind, Placebo-controlled, Parallel-group, Multi-centre Study of the Efficacy and Safety of GSK3511294 Adjunctive Therapy in Adult and Adolescent Participants With Severe Uncontrolled Asthma With an Eosinophilic Phenotype
A 52-week, Randomised, Double-blind, Placebo-controlled, Parallel-group, Multi-centre Study of the Efficacy and Safety of GSK3511294 Adjunctive Therapy in Adult and Adolescent Participants With Severe Uncontrolled Asthma With an Eosinophilic Phenotype
Enrollment Status: Completed
Publish Date: November 29, 2024
Intervention Type: Biological
Study Drug: Depemokimab
Study Phase: Phase 3
A Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine Over 24 Weeks in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
A Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine Over 24 Weeks in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
Enrollment Status: Completed
Publish Date: October 16, 2023
Intervention Type: Drug
Study Drug: Ensifentrine
Study Phase: Phase 3
A Phase 2, Randomized, Partially-blinded, Parallel Group, Dose-ranging Study to Assess the Pharmacodynamics, Relative Bioavailability, and Safety of of Tiotropium Bromide Inhalation Solution in Subjects With COPD
A Phase 2, Randomized, Partially-blinded, Parallel Group, Dose-ranging Study to Assess the Pharmacodynamics, Relative Bioavailability, and Safety of of Tiotropium Bromide Inhalation Solution in Subjects With COPD
Enrollment Status: Completed
Publish Date: May 10, 2021
Intervention Type: Drug
Study Drug: Tiotropium Bromide Inhalation Solution
Study Phase: Phase 2
View 6 Less Clinical Trials

3 Total Publications

Corrigendum to "A multicenter, randomized, double-blind dose-ranging study of glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler compared to the monocomponents and open-label tiotropium dry powder inhaler in patients with moderate-to-severe COPD" [Respir. Med. 120 November 2016 16-24].
Corrigendum to "A multicenter, randomized, double-blind dose-ranging study of glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler compared to the monocomponents and open-label tiotropium dry powder inhaler in patients with moderate-to-severe COPD" [Respir. Med. 120 November 2016 16-24].
Journal: Respiratory medicine
Published: July 23, 2017
View All 3 Publications
Similar Doctors
Experienced in Aspergillosis
Dr. Carmine Dalto
Pulmonary Medicine | Intensive Care Medicine
Experienced in Aspergillosis
Dr. Carmine Dalto
Pulmonary Medicine | Intensive Care Medicine

Caromont Medical Group Inc

2525 Court Dr, 
Gastonia, NC 
 (21.1 miles away)
704-834-2450
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Carmine Dalto is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Gastonia, North Carolina. Dr. Dalto is rated as an Advanced provider by MediFind in the treatment of Aspergillosis. His top areas of expertise are Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Pneumonia, and Acute Interstitial Pneumonia. Dr. Dalto is currently accepting new patients.

Experienced in Aspergillosis
Dr. Laura Peno
Pulmonary Medicine
Experienced in Aspergillosis
Dr. Laura Peno
Pulmonary Medicine

Caromont Pulmonary Medicine

934 Cox Rd, 
Gastonia, NC 
 (21.3 miles away)
980-834-5864
Languages Spoken:
English
See accepted insurances

Laura Peno is a Pulmonary Medicine provider in Gastonia, North Carolina. Dr. Peno is rated as an Advanced provider by MediFind in the treatment of Aspergillosis. Her top areas of expertise are Bronchiolitis Obliterans, Industrial Bronchitis, Lung Metastases, and Chronic Obstructive Pulmonary Disease (COPD).

Experienced in Aspergillosis
Dr. Sever Surdulescu
Pulmonary Medicine
Experienced in Aspergillosis
Dr. Sever Surdulescu
Pulmonary Medicine

Mooresville Surgical Associates

123 Professional Park Dr Ste 200, 
Mooresville, NC 
 (42.4 miles away)
704-660-4094
Languages Spoken:
English
See accepted insurances

Sever Surdulescu is a Pulmonary Medicine provider in Mooresville, North Carolina. Dr. Surdulescu is rated as an Advanced provider by MediFind in the treatment of Aspergillosis. His top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Obstructive Sleep Apnea, Lung Nodules, and Excessive Daytime Sleepiness.

VIEW MORE ASPERGILLOSIS DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Denenberg's expertise for a condition
ConditionClose
    • Distinguished
    • Bullae
      Dr. Denenberg is
      Distinguished
      . Learn about Bullae.
      See more Bullae experts
    • Emphysema
      Dr. Denenberg is
      Distinguished
      . Learn about Emphysema.
      See more Emphysema experts
    • Advanced
    • ALK-Positive Non-Small Cell Lung Cancer
      Dr. Denenberg is
      Advanced
      . Learn about ALK-Positive Non-Small Cell Lung Cancer.
      See more ALK-Positive Non-Small Cell Lung Cancer experts
    • Bronchiectasis
      Dr. Denenberg is
      Advanced
      . Learn about Bronchiectasis.
      See more Bronchiectasis experts
    • Lung Cancer
      Dr. Denenberg is
      Advanced
      . Learn about Lung Cancer.
      See more Lung Cancer experts
    • Lung Metastases
      Dr. Denenberg is
      Advanced
      . Learn about Lung Metastases.
      See more Lung Metastases experts
    • Obstructive Sleep Apnea
      Dr. Denenberg is
      Advanced
      . Learn about Obstructive Sleep Apnea.
      See more Obstructive Sleep Apnea experts
    • Pleural Effusion
      Dr. Denenberg is
      Advanced
      . Learn about Pleural Effusion.
      See more Pleural Effusion experts
    View All 11 Advanced Conditions
    • Experienced
    • Acute Interstitial Pneumonia
      Dr. Denenberg is
      Experienced
      . Learn about Acute Interstitial Pneumonia.
      See more Acute Interstitial Pneumonia experts
    • Advanced Bronchoscopy
      Dr. Denenberg is
      Experienced
      . Learn about Advanced Bronchoscopy.
      See more Advanced Bronchoscopy experts
    • Allergic Bronchopulmonary Aspergillosis
      Dr. Denenberg is
      Experienced
      . Learn about Allergic Bronchopulmonary Aspergillosis.
      See more Allergic Bronchopulmonary Aspergillosis experts
    • Alpha-1 Antitrypsin Deficiency (AATD)
      Dr. Denenberg is
      Experienced
      . Learn about Alpha-1 Antitrypsin Deficiency (AATD).
      See more Alpha-1 Antitrypsin Deficiency (AATD) experts
    • Aspergillosis
      Dr. Denenberg is
      Experienced
      . Learn about Aspergillosis.
      See more Aspergillosis experts
    • Asthma
      Dr. Denenberg is
      Experienced
      . Learn about Asthma.
      See more Asthma experts
    View All 30 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.